Andere Suchmöglichkeiten:
1.6.1 institution » 5.2.2 institution, 3.3.1 institutional, 5.2.1 institutionen
institution after » distribution after, institution en, institution based
inhibition after » infection after, inhibition assay
kanal inhibition » lateral inhibition, ncx inhibition, pain inhibition
1.6.1 inhibition » 3.10.1 inhibition, 1.9 inhibition, 4.4.4 inhibition
bias inhibition » site inhibition, vitro inhibition
cva inhibition » c5 inhibition, _ inhibition, 1.9 inhibition
pain inhibitor » pain inhibition, pump inhibitor, 2a inhibitor
1.6.1 institution » 5.2.2 institution, 3.3.1 institutional, 5.2.1 institutionen
institution after » distribution after, institution en, institution based
inhibition after » infection after, inhibition assay
kanal inhibition » lateral inhibition, ncx inhibition, pain inhibition
1.6.1 inhibition » 3.10.1 inhibition, 1.9 inhibition, 4.4.4 inhibition
bias inhibition » site inhibition, vitro inhibition
cva inhibition » c5 inhibition, _ inhibition, 1.9 inhibition
pain inhibitor » pain inhibition, pump inhibitor, 2a inhibitor
1
2
Falke, Isabel, Troschel, Fabian Martin, Palenta, Heike, Löblein, Maria T., Brüggemann, Kathrin, Borrmann, Katrin, Eich, Hans-Theodor, Götte, Martin, Greve, Burkhard
2022
Schlagwörter:
“...Musashi-1 Cancer stem cell Endometrial cancer Proliferation Radioresistance...”2022
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Krekeler, Carolin, Wethmar, Klaus, Mikesch, Jan-Henrik, Kerkhoff, Andrea, Menck, Kerstin, Lenz, Georg, Schildhaus, Hans-Ulrich, Wessolly, Michael, Hoffmann, Matthias W., Pascher, Andreas, Asmus, Inga, Wardelmann, Eva, Bleckmann, Annalen
2023
Schlagwörter:
“...immune checkpoint inhibition nivolumab ipilimumab microsatellite instability metastatic colorectal...”2023
17
18
19
Ventura, David, Schindler, Philipp, Masthoff, Max, Görlich, Dennis, Dittmann, Matthias, Heindel, Walter, Schäfers, Michael, Lenz, Georg, Wardelmann, Eva, Mohr, Michael, Kies, Peter, Bleckmann, Annalen, Roll, Wolfgang, Evers, Georg Heribert
2023
Schlagwörter:
“...radiomics FDG-PET-CT NSCLC PD-L1 PD-1 immune checkpoint inhibition pembrolizumab artificial...”2023
20